Immunomedics (IMMU) Prices 14.736M Share Common Offering at $28.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Pre-Open Movers 04/28: (IBIO) (RTIX) (FFIV) Higher; (NBES) (HLIT) (GAIA) Lower (more...)
April 28, 2020 9:27 AM EDTToday's Pre-Open Stock Movers
iBio, Inc. (NYSE: IBIO) 50% HIGHER; provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), one of 14 institutes in the Manufacturing USA Network.
RTI Surgical Holdings, Inc. (Nasdaq: RTIX) 29.9% HIGHER; announces a second amendment to its definitive agreement for the sale of RTI Surgical Holdings' OEM business to Montagu Private Equity LLP. Reduces the cash purchase price from $480,000,000 to... More
After-Hours Movers 04/27: (RTIX) (IBIO) (QTNT) Higher; (GAIA) (NBSE) (HLIT) Lower (more...)
April 27, 2020 5:54 PM EDTToday's After-Hours Movers
RTI Surgical Holdings, Inc. (Nasdaq: RTIX) 52% HIGHER; announces a second amendment to its definitive agreement for the sale of RTI Surgical Holdings' OEM business to Montagu Private Equity LLP. Reduces the cash purchase price from $480,000,000 to $440,000,000.
iBio, Inc. (NYSE: IBIO) 25.5% HIGHER; provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), one of 14 institutes in the Manufacturing USA Network.
Gaia, Inc. (NASDAQ:... More
Immunomedics (IMMU) Announces Proposed $350M Public Offering Of Common Stock
April 27, 2020 4:02 PM EDTImmunomedics, Inc. (NASDAQ: IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates, today... More
